BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 20558726)

  • 1. BCL-3 degradation involves its polyubiquitination through a FBW7-independent pathway and its binding to the proteasome subunit PSMB1.
    Keutgens A; Zhang X; Shostak K; Robert I; Olivier S; Vanderplasschen A; Chapelle JP; Viatour P; Merville MP; Bex F; Gothot A; Chariot A
    J Biol Chem; 2010 Aug; 285(33):25831-40. PubMed ID: 20558726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic screen reveals Fbw7 as a modulator of the NF-κB pathway.
    Arabi A; Ullah K; Branca RM; Johansson J; Bandarra D; Haneklaus M; Fu J; Ariës I; Nilsson P; Den Boer ML; Pokrovskaja K; Grandér D; Xiao G; Rocha S; Lehtiö J; Sangfelt O
    Nat Commun; 2012; 3():976. PubMed ID: 22864569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of GATA-binding protein 2 levels via ubiquitin-dependent degradation by Fbw7: involvement of cyclin B-cyclin-dependent kinase 1-mediated phosphorylation of THR176 in GATA-binding protein 2.
    Nakajima T; Kitagawa K; Ohhata T; Sakai S; Uchida C; Shibata K; Minegishi N; Yumimoto K; Nakayama KI; Masumoto K; Katou F; Niida H; Kitagawa M
    J Biol Chem; 2015 Apr; 290(16):10368-81. PubMed ID: 25670854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The repressing function of the oncoprotein BCL-3 requires CtBP, while its polyubiquitination and degradation involve the E3 ligase TBLR1.
    Keutgens A; Shostak K; Close P; Zhang X; Hennuy B; Aussems M; Chapelle JP; Viatour P; Gothot A; Fillet M; Chariot A
    Mol Cell Biol; 2010 Aug; 30(16):4006-21. PubMed ID: 20547759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ERK kinase phosphorylates and destabilizes the tumor suppressor FBW7 in pancreatic cancer.
    Ji S; Qin Y; Shi S; Liu X; Hu H; Zhou H; Gao J; Zhang B; Xu W; Liu J; Liang D; Liu L; Liu C; Long J; Zhou H; Chiao PJ; Xu J; Ni Q; Gao D; Yu X
    Cell Res; 2015 May; 25(5):561-73. PubMed ID: 25753158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stringent Control of NFE2L3 (Nuclear Factor, Erythroid 2-Like 3; NRF3) Protein Degradation by FBW7 (F-box/WD Repeat-containing Protein 7) and Glycogen Synthase Kinase 3 (GSK3).
    Kannan MB; Dodard-Friedman I; Blank V
    J Biol Chem; 2015 Oct; 290(43):26292-302. PubMed ID: 26306035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fbxw7 acts as an E3 ubiquitin ligase that targets c-Myb for nemo-like kinase (NLK)-induced degradation.
    Kanei-Ishii C; Nomura T; Takagi T; Watanabe N; Nakayama KI; Ishii S
    J Biol Chem; 2008 Nov; 283(45):30540-8. PubMed ID: 18765672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The hormone-bound vitamin D receptor enhances the FBW7-dependent turnover of NF-κB subunits.
    Fekrmandi F; Wang TT; White JH
    Sci Rep; 2015 Aug; 5():13002. PubMed ID: 26269414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SCF(Fbw7) modulates the NFkB signaling pathway by targeting NFkB2 for ubiquitination and destruction.
    Fukushima H; Matsumoto A; Inuzuka H; Zhai B; Lau AW; Wan L; Gao D; Shaik S; Yuan M; Gygi SP; Jimi E; Asara JM; Nakayama K; Nakayama KI; Wei W
    Cell Rep; 2012 May; 1(5):434-43. PubMed ID: 22708077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isoform-specific SCF(Fbw7) ubiquitination mediates differential regulation of PGC-1α.
    Trausch-Azar JS; Abed M; Orian A; Schwartz AL
    J Cell Physiol; 2015 Apr; 230(4):842-52. PubMed ID: 25204433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Fbw7 tumor suppressor regulates nuclear factor E2-related factor 1 transcription factor turnover through proteasome-mediated proteolysis.
    Biswas M; Phan D; Watanabe M; Chan JY
    J Biol Chem; 2011 Nov; 286(45):39282-9. PubMed ID: 21953459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SCF-mediated degradation of p100 (NF-κB2): mechanisms and relevance in multiple myeloma.
    Busino L; Millman SE; Pagano M
    Sci Signal; 2012 Dec; 5(253):pt14. PubMed ID: 23211527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Bcl-3 oncoprotein acts as a bridging factor between NF-kappaB/Rel and nuclear co-regulators.
    Dechend R; Hirano F; Lehmann K; Heissmeyer V; Ansieau S; Wulczyn FG; Scheidereit C; Leutz A
    Oncogene; 1999 Jun; 18(22):3316-23. PubMed ID: 10362352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MDM2 and Fbw7 cooperate to induce p63 protein degradation following DNA damage and cell differentiation.
    Galli F; Rossi M; D'Alessandra Y; De Simone M; Lopardo T; Haupt Y; Alsheich-Bartok O; Anzi S; Shaulian E; Calabrò V; La Mantia G; Guerrini L
    J Cell Sci; 2010 Jul; 123(Pt 14):2423-33. PubMed ID: 20571051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fbw7 promotes ubiquitin-dependent degradation of c-Myb: involvement of GSK3-mediated phosphorylation of Thr-572 in mouse c-Myb.
    Kitagawa K; Hiramatsu Y; Uchida C; Isobe T; Hattori T; Oda T; Shibata K; Nakamura S; Kikuchi A; Kitagawa M
    Oncogene; 2009 Jun; 28(25):2393-405. PubMed ID: 19421138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The glomuvenous malformation protein Glomulin binds Rbx1 and regulates cullin RING ligase-mediated turnover of Fbw7.
    Tron AE; Arai T; Duda DM; Kuwabara H; Olszewski JL; Fujiwara Y; Bahamon BN; Signoretti S; Schulman BA; DeCaprio JA
    Mol Cell; 2012 Apr; 46(1):67-78. PubMed ID: 22405651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7.
    Wertz IE; Kusam S; Lam C; Okamoto T; Sandoval W; Anderson DJ; Helgason E; Ernst JA; Eby M; Liu J; Belmont LD; Kaminker JS; O'Rourke KM; Pujara K; Kohli PB; Johnson AR; Chiu ML; Lill JR; Jackson PK; Fairbrother WJ; Seshagiri S; Ludlam MJ; Leong KG; Dueber EC; Maecker H; Huang DC; Dixit VM
    Nature; 2011 Mar; 471(7336):110-4. PubMed ID: 21368834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E3 ubiquitin ligase Fbw7 negatively regulates granulocytic differentiation by targeting G-CSFR for degradation.
    Lochab S; Pal P; Kapoor I; Kanaujiya JK; Sanyal S; Behre G; Trivedi AK
    Biochim Biophys Acta; 2013 Dec; 1833(12):2639-2652. PubMed ID: 23820376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The p105 NF-ĸB precursor is a pseudo substrate of the ubiquitin ligase FBXO7, and its binding to the ligase stabilizes it and results in stimulated cell proliferation.
    Udasin RG; Gottfried Y; Fabre B; Bercovich B; Ziv T; Ciechanover A
    Biochem Biophys Res Commun; 2021 Jun; 558():224-230. PubMed ID: 32933748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation.
    Welcker M; Orian A; Jin J; Grim JE; Harper JW; Eisenman RN; Clurman BE
    Proc Natl Acad Sci U S A; 2004 Jun; 101(24):9085-90. PubMed ID: 15150404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.